ORAL CONTROLLED RELEASE METFORMIN HYDROCHLORIDE ION EXCHANGE RESINATE BEADS

Authors

  • Ajit S. Raghuwanshi Department of Chemistry, The University of Warwick, Coventry
  • Ajay S. Raghuwanshi Bhopal Institute of Technology & Science-Pharmacy, Bhojpur Road, Bhopal (MP)
  • U. K. Jain

DOI:

https://doi.org/10.7439/ijbar.v1i4.8

Keywords:

Synchronous tumors, cervical cancer, ovarian carcinoma

Abstract

Treating with ion exchange resin has chemically modified metformin hydrochloride to form an oral controlled release beads using ion-exchange resin sorption method. A strong cation exchange resin Amberlite IR 120 was utilized for the sorption of the drug and the drug resinates was evaluated for various physical and chemical parameters. The drug content and percentage drug release were determined spectrophotometrically at 233 nm. About 43% of drug was loaded in 4.5 h and in-vitro dissolution study showed 84% of drug release in 8 h. The drug-resinate complex was microencapsulated with a polymer Eudragit RS 100 to further retard the release characteristics. Further, the drug-resinate complex and microencapsulated drug resinate were suspended in a palatable aqueous suspension base and were evaluated for controlled release characteristic.

Downloads

Download data is not yet available.

Downloads

Published

2010-12-01

Issue

Section

Original Research Articles

How to Cite

ORAL CONTROLLED RELEASE METFORMIN HYDROCHLORIDE ION EXCHANGE RESINATE BEADS. (2010). International Journal of Biomedical and Advance Research, 1(4), 103-108. https://doi.org/10.7439/ijbar.v1i4.8